Abbott Laboratories (XSWX:ABT) Accounts Payable: CHF3,684 Mil (As of Mar. 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF74.50
GF Value CHF105.05
View Full Analysis

What is Abbott Laboratories Accounts Payable?

Abbott Laboratories XSWX:ABT 80 Accounts Payable is CHF3,684 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF105.05.

Abbott Laboratories's Accounts Payable for the quarter that ended in Mar. 2026 was CHF3,684 Mil.

Abbott Laboratories's quarterly Accounts Payable increased from Sep. 2025 (CHF3,282 Mil) to Dec. 2025 (CHF3,379 Mil) and increased from Dec. 2025 (CHF3,379 Mil) to Mar. 2026 (CHF3,684 Mil).

Abbott Laboratories's annual Accounts Payable increased from Dec. 2023 (CHF3,714 Mil) to Dec. 2024 (CHF3,740 Mil) but then declined from Dec. 2024 (CHF3,740 Mil) to Dec. 2025 (CHF3,379 Mil).

Abbott Laboratories Accounts Payable Related Terms

Abbott Laboratories Accounts Payable Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Accounts Payable Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,059.77 4,291.88 3,714.32 3,740.26 3,378.86

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,723.49 3,501.64 3,282.32 3,378.86 3,683.78
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of CHF3,684 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Accounts Payable of CHF3,684 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Accounts Payable too high?
Abbott Laboratories' current Accounts Payable is CHF3,684 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Accounts Payable compare to SYK and MDT?
Abbott Laboratories' Accounts Payable of CHF3,684 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Accounts Payable is CHF3,684 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Accounts Payable of CHF3,684 Mil. The stock's GF Value™ is CHF105.05, compared to a current price of CHF74.50 — trading 29.1% below its estimated fair value. The current Accounts Payable is CHF3,684 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Accounts Payable is CHF3,684 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF74.50 is trading 29.1% below its estimated GF Value™ of CHF105.05.

Key valuation signals for XSWX:ABT:

  • Accounts Payable: CHF3,684 Mil
  • GF Value™: CHF105.05 vs. price of CHF74.50 (29.1% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.50
Price
CHF105.05
GF Value